162 related articles for article (PubMed ID: 22935939)
1. Cost-benefit and cost-savings analyses of antiarrhythmic medication monitoring.
Snider M; Carnes C; Grover J; Davis R; Kalbfleisch S
Am J Health Syst Pharm; 2012 Sep; 69(18):1569-73. PubMed ID: 22935939
[TBL] [Abstract][Full Text] [Related]
2. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
de Oliveira DR; Brummel AR; Miller DB
J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a pharmacist-managed amiodarone monitoring program.
Spence MM; Polzin JK; Weisberger CL; Martin JP; Rho JP; Willick GH
J Manag Care Pharm; 2011 Sep; 17(7):513-22. PubMed ID: 21870892
[TBL] [Abstract][Full Text] [Related]
4. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.
Snider M; Kalbfleisch S; Carnes CA
Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a pharmacist-run antiarrhythmic clinic in an ambulatory practice.
Lifer SM; Musser MR; Kier KL
J Am Pharm Assoc (2003); 2015; 55(5):546-51. PubMed ID: 26208334
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
Tate ML; Hopper S; Bergeron SP
J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review.
Wang Y; Yeo QQ; Ko Y
Diabet Med; 2016 Apr; 33(4):421-7. PubMed ID: 26433008
[TBL] [Abstract][Full Text] [Related]
8. Improving cost-effectiveness of and outcomes from drug therapy in patients with atrial fibrillation in managed care: role of the pharmacist.
Johnson SG
J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S19-25. PubMed ID: 19678723
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a pharmacist-managed electrolyte protocol in outpatients on antiarrhythmic medications.
Long VP; Carnes CA; Vecchiet J; Houmsse M; Hirsch A; Snider MJ
J Am Pharm Assoc (2003); 2017; 57(4):526-531. PubMed ID: 28610942
[TBL] [Abstract][Full Text] [Related]
10. PharmacistCARE: description of a pharmacist care service and lessons learned along the way.
Divine H; Nicholas A; Johnson CL; Perrier DG; Steinke DT; Blumenschein K
J Am Pharm Assoc (2003); 2008; 48(6):793-802. PubMed ID: 19019810
[TBL] [Abstract][Full Text] [Related]
11. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
[TBL] [Abstract][Full Text] [Related]
12. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.
Till LT; Voris JC; Horst JB
J Manag Care Pharm; 2003; 9(3):269-73. PubMed ID: 14613471
[TBL] [Abstract][Full Text] [Related]
13. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
14. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care.
Aziz F; Corder M; Wolffe J; Comerota AJ
J Vasc Surg; 2011 Nov; 54(5):1404-7. PubMed ID: 21741791
[TBL] [Abstract][Full Text] [Related]
16. Michigan Pharmacists Transforming Care and Quality: Developing a Statewide Collaborative of Physician Organizations and Pharmacists to Improve Quality of Care and Reduce Costs.
Choe HM; Lin AT; Kobernik K; Cohen M; Wesolowicz L; Qureshi N; Leyden T; Share DA; Darland R; Spahlinger DA
J Manag Care Spec Pharm; 2018 Apr; 24(4):373-378. PubMed ID: 29578853
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of expanded use of clinical pharmacist practitioners in addition to team-based care in a community health system intensive care unit.
Michalets E; Creger J; Shillinglaw WR
Am J Health Syst Pharm; 2015 Jan; 72(1):47-53. PubMed ID: 25511838
[TBL] [Abstract][Full Text] [Related]
18. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
Bagwell A; Kelley T; Carver A; Lee JB; Newman B
J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of pharmacist-led medication reviews in residential aged care facilities.
Hasan SS; Thiruchelvam K; Kow CS; Ghori MU; Babar ZU
Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):431-439. PubMed ID: 28825502
[TBL] [Abstract][Full Text] [Related]
20. Economic impact of pharmacist-reimbursed drug therapy modification.
Look KA; Mott DA; Kreling DH; Peterson EJ; Staresinic AG
J Am Pharm Assoc (2003); 2011; 51(1):58-64. PubMed ID: 21247827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
